Michael Mulcahy
· Senior Lecturer of the Canberra School of Music at the Australian National University, Visiting Artist at the Australian National Academy of Music in Melbourne, and Artist in Residence at Indiana University and Wiley Housewright Scholar at Florida State UniversityNorthwestern University · Strings
Active 1999–2026
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Michael Mulcahy is a distinguished trombone player and educator with a background that includes extensive international performance and teaching experience. He has appeared as a soloist and teacher across the United States, Canada, United Kingdom, Ireland, Germany, Holland, Italy, Sweden, Denmark, Russia, Japan, China, Argentina, New Zealand, and Australia. His notable performances include appearances as a soloist with the Chicago Symphony Orchestra and Pierre Boulez in music of Elliot Carter, and with Daniel Barenboim in Leopold Mozart’s Concerto for Alto Trombone. He has also performed with the Bavarian Radio Symphony Orchestra, the Hilversum Radio Symphony Orchestra, and on tour with the Melbourne Symphony Orchestra. In October 2016, he gave the world premiere of Five Hallucinations by Carl Vine, a solo concerto co-commissioned by the Chicago Symphony and the Sydney Symphony. In 2018, he was featured in the world premiere of the Low Brass Concerto of Jennifer Higdon with the Chicago Symphony and Riccardo Muti. Mulcahy is the winner of several international competitions, including the Australian Broadcasting Corporation Instrumental Competition, the ARD International Music Competition in Munich, the Viotti International Competition in Italy, and the International Instrumental Competition in Markneukirchen. Appointed by Sir Georg Solti, he joined the Chicago Symphony Orchestra in 1989 and has served as Principal Trombone with various orchestras, including the Music of the…
Research topics
- Internal medicine
- Medicine
- Oncology
- Intensive care medicine
- General surgery
- Family medicine
Selected publications
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
The Lancet · 2020 · 1798 citations
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 1726 citations
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colorectal cancer (mCRC), because important updates have recently been made to this section. These updates include recommendations for first-line use of checkpoint inhibitors for mCRC, that is deficient mismatch repair/microsatellite instability-high, recommendations related to the use of biosimilars, and expanded recommendat…
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 1674 citations
Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of gastric cancers are adenocarcinomas, which are typically classified based on anatomic location and histologic type. Gastric cancer generally carries a poor prognosis because it is often diagnosed at an advanced stage. Systemic therapy can provide palliation, improved survival, and enhanced quality of life in patients with locally advanced or metastatic disease. The implementation of biomarker testing, espec…
Journal of the National Comprehensive Cancer Network · 2023 · 499 citations
Cancers originating in the esophagus or esophagogastric junction constitute a major global health problem. Esophageal cancers are histologically classified as squamous cell carcinoma (SCC) or adenocarcinoma, which differ in their etiology, pathology, tumor location, therapeutics, and prognosis. In contrast to esophageal adenocarcinoma, which usually affects the lower esophagus, esophageal SCC is more likely to localize at or higher than the tracheal bifurcation. Systemic therapy can provide pall…
Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2024-06-01 · 290 citations
articleOpen accessColorectal cancer (CRC) is the fourth most frequently diagnosed cancer and the second leading cause of cancer death in the United States. Management of disseminated metastatic CRC involves various active drugs, either in combination or as single agents. The choice of therapy is based on consideration of the goals of therapy, the type and timing of prior therapy, the mutational profile of the tumor, and the differing toxicity profiles of the constituent drugs. This manuscript summarizes the data…
Frequent coauthors
- 267 shared
Al B. Benson
Northwestern University
- 205 shared
Hedy L. Kindler
University of Chicago
- 185 shared
Riad Salem
Northwestern University
- 173 shared
Donna Niedzwiecki
Duke University
- 157 shared
Eileen M. O’Reilly
Memorial Sloan Kettering Cancer Center
- 157 shared
Federico Innocenti
University of North Carolina at Chapel Hill
- 150 shared
Robert J. Lewandowski
Northwestern University
- 145 shared
Alan P. Venook
Education
- 1987
B.S., Music
Australian National University
- 1999
M.A., Trombone Performance
Northwestern University
Similar researchers at Northwestern University
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Michael Mulcahy
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup